Showing results (31-40 of 107) with videos related to
Sort By:
Pageof 11
Journal of Cell Science|July 2, 2010
Charged residues in the C-terminus of the P2Y1 receptor constitute a basolateral-sorting signalSamuel C Wolff, Ai-Dong Qi, T Kendall Harden, et al.The Journal of Biological Chemistry|September 4, 2008
Dual activation of phospholipase C-epsilon by Rho and Ras GTPasesJason P Seifert, Yixing Zhou, Stephanie N Hicks, et al.Bioorganic & Medicinal Chemistry|July 27, 2012
Virtual screening leads to the discovery of novel non-nucleotide P2Y₁ receptor antagonistsStefano Costanzi, T Santhosh Kumar, Ramachandran Balasubramanian, et al.Methods in Enzymology|February 14, 2006
Regulation of PLCbeta isoforms by RacJason T Snyder, Mark R Jezyk, Svetlana Gershburg, et al.Journal of Medicinal Chemistry|April 5, 2007
Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptorHyojin Ko, Ingrid Fricks, Andrei A Ivanov, et al.The Journal of Biological Chemistry|December 24, 2008
Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoformJiyoung Y Cha, Savitri Maddileti, Natalia Mitin, et al.Biochemistry|June 20, 2013
Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymesNicole Hajicek, Thomas H Charpentier, Jeremy R Rush, et al.British Journal of Pharmacology|November 22, 2005
[32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptorsDayle Houston, Michihiro Ohno, Robert A Nicholas, et al.The Journal of Biological Chemistry|July 31, 2003
Requirement of Cys399 for processing of the human ecto-ATPase (NTPDase2) and its implications for determination of the activities of splice variants of the enzymeJesús Mateo, Silvia Kreda, Christopher E Henry, et al.Journal of Medicinal Chemistry|May 16, 2003
C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonistsMyoung Goo Kim, Erik T Bodor, Chen Wang, et al.Pageof 11